Postoperative Pain Management of Caesarean Section

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

February 23, 2022

Primary Completion Date

April 30, 2026

Study Completion Date

July 31, 2026

Conditions
Postoperative PainCaesarean SectionAnalgesia
Interventions
DRUG

Intravenous patient-control analgesia

At the two trial sites, IV-PCA is commonly used with morphine. The device is installed after delivery and removed within 3 days.

DRUG

Dinalbuphine sebacate

Dinalbuphine sebacate is a prodrug of nalbuphine. With oil-based formulation, the active ingredient releases slowly and the effect lasts longer than nalbuphine. After delivery, a single 150 mg dose of dinalbuphine sebacate is administered intramuscularly.

Trial Locations (2)

104

NOT_YET_RECRUITING

MacKay Memorial Hospital, Taipei

251

RECRUITING

MacKay Memorial Hospital Tamsui Branch, New Taipei City

All Listed Sponsors
lead

Mackay Memorial Hospital

OTHER